Gilead Sciences, inc. Stock's Green Light Sparks Offensive
Gilead Sciences will need to convince healthcare payers to prescribe its new hepatitis C drug Harvoni.
The Most Important Number You Need to Know Before Buying Gilead Sciences Inc. Stock
Gilead's future is almost entirely dependent on Sovaldi's success. How high is the ceiling for this one-of-a-kind blockbuster drug?